Crohn's Disease Treatment in Nagpur

Crohn’s Disease Types and Location

Ileocolitis (Most Common – 50%)

Affects the terminal ileum and colon causing inflammation in the junction area. Presents with diarrhea, abdominal pain, weight loss, and potential complications. Ileocolitis requires aggressive medical management to prevent obstruction and fistula formation.

Ileitis (30%)

Limited to the small bowel (ileum) causing cramping pain and diarrhea. Small bowel involvement complicates diagnosis requiring capsule endoscopy or MR enterography. Nutritional complications occur with extensive small bowel disease.

Colitis (20%)

Affects the colon exclusively causing bloody diarrhea and urgency. Colitis increases colorectal cancer risk requiring increased surveillance. Left-sided colitis mimics ulcerative colitis requiring careful differentiation.

Crohn’s Disease Symptoms

• Chronic diarrhea (watery or bloody)

• Abdominal pain and cramping

• Weight loss and failure to thrive

• Fever and malaise

• Bloody stools (less common than UC)

• Perianal fistulas and abscesses

• Joint pain (arthralgia)

• Eye inflammation (uveitis)

• Skin manifestations (erythema nodosum)

• Mouth ulcers and canker sores

Symptom severity ranges from mild to severely disabling depending on disease extent and activity level.

Crohn’s Disease Causes and Risk Factors

Genetic Predisposition

• Family history (15-20% have affected relatives)

• Multiple susceptibility genes identified

• Increased risk in Jewish populations

• Concordance in monozygotic twins

Environmental Triggers

• Smoking significantly worsens disease

• Bacterial infections triggering immune response

• Diet rich in processed foods

• Antibiotic use altering microbiota

• Psychological stress exacerbating symptoms

Immune Dysfunction

• Abnormal intestinal barrier function

• Dysregulated immune response to normal flora

• Increased intestinal permeability

• Impaired mucosal healing mechanisms

Microbiota Alterations

• Dysbiosis (reduced microbial diversity)

• Decreased protective bacteria

• Increased pathogenic organisms

• Compromised intestinal ecosystem

Crohn’s Disease Diagnosis

Clinical Assessment

• Symptom duration (>4 weeks typically required)

• Disease pattern and severity

• Extra-intestinal manifestations

• Family history evaluation

Laboratory Tests

• Inflammatory markers (elevated CRP, ESR)

• Fecal calprotectin (intestinal inflammation)

• Complete blood count (anemia assessment)

• Nutritional assessment (albumin, vitamins)

Imaging Studies

• CT enterography (assesses inflammation and complications)

• MR enterography (avoids radiation exposure)

• Ultrasound (initial assessment)

• Barium studies (bowel anatomy)

Endoscopic Evaluation

• Colonoscopy with ileoscopy (visualizes disease)

• Biopsies confirming diagnosis

• Assessment of strictures and fistulas

• Surveillance for dysplasia/cancer

Crohn’s Disease Treatment

First-Line Therapy (Mild-Moderate Disease)

5-Aminosalicylates (5-ASA)

• Mesalamine 2.4-4.8 grams daily

• Anti-inflammatory effects

• Effective for mild colonic disease

• Limited role in small bowel disease

• Maintenance therapy after remission

Corticosteroids (Acute Flares)

• Prednisone 40-60 mg daily tapering

• Induces remission in 70% of patients

• Not suitable for maintenance (side effects)

• Should be tapered to discontinuation

Second-Line Therapy (Moderate-Severe Disease)

Immunomodulators

• Azathioprine: Steroid-sparing effect

• 6-Mercaptopurine: Alternative immunosuppression

• Methotrexate: Reduces steroid dependence

• Delayed onset (6-12 weeks)

Biological Agents (TNF-Alpha Inhibitors)

• Infliximab: IV infusions every 8 weeks

• Adalimumab: Subcutaneous injections

• Certolizumab pegol: Monthly injections

• 60-70% remission rates in moderate-severe disease

• Most effective agents available

Newer Biologics

• Vedolizumab (integrin antagonist)

• Ustekinumab (IL-12/IL-23 inhibitor)

• Excellent efficacy and safety profile

Nutritional Support

• High-calorie diet during remission

• Elemental diet during flares

• Vitamin supplementation (B12, folate, iron)

• Fat-soluble vitamins (A, D, E, K)

• Zinc supplementation if deficient

Dietary Modifications

• Low-residue diet during inflammation

• Avoid high-fat foods triggering diarrhea

• Limit dairy if lactose intolerant

• Eliminate triggers (spicy foods, alcohol)

Crohn’s Disease Complications

• Intestinal obstruction: Stricture formation narrowing bowel lumen

• Fistulas: Abnormal connections between bowel segments or organs

• Abscesses: Localized infection requiring drainage

• Perianal disease: Fistulas and abscess near anus

• Toxic megacolon: Severe colonic dilation (emergency)

• Colorectal cancer: Increased risk with extensive colitis

• Growth retardation: In children with active disease

• Malabsorption: From extensive small bowel involvement

• Extraintestinal manifestations: Arthritis, uveitis, skin disease

Crohn’s Disease Surveillance and Monitoring

Clinical Monitoring

• Monthly visits during active disease

• Every 3 months on maintenance therapy

• Assessment of disease activity

• Medication tolerance monitoring

Colonoscopic Surveillance

• Baseline colonoscopy at diagnosis

• Follow-up colonoscopy 1-2 years post-treatment

• Annual surveillance if colonic involvement

• More frequent if dysplasia detected

Cancer Screening

• Colonoscopy with biopsies every 1-2 years

• Increased risk after 8-10 years of colitis

• Earlier screening in extensive disease

• Enhanced surveillance if primary sclerosing cholangitis

Crohn’s Disease Prevention and Remission Maintenance

• Smoking cessation: Critical for disease control

• Medication adherence: Essential for remission maintenance

• Stress management: Reduces flare frequency

• Regular monitoring: Early detection of complications

• Dietary vigilance: Avoid identified triggers

• Immunizations: Keep vaccinations current before biologics

• Colonoscopic surveillance: Prevent cancer complications